63. [IF=3.1] Zhiyuan Ding et al."Comparisons of the bioavailability of icariin, icariside II, and epimedin C in rats after oral administration of total flavonoids of Epimedium brevicornu Maxim. and its three formulations."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALY 62. [IF=2.6] Shili Pan et al."Formation and stabilization mechanism of Ginsenoside Rg3 inclusion complexes based on molecular simulation."PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY. 61. [IF=11] Hongcai Li et al."Biodegradable multifunctional hydroxypropyl-β-cyclodextrin@EGCG/lignin/ gelatin composite films based on incorporating lignin and loaded EGCG for fruit preservation."FOOD HYDROCOLLOIDS.2025 Jul;164:111206 60. [IF=5.6] Chao Zhang et al."Cyclodextrin inclusion complex enhances solubility and antimicrobial activity of chlortetracycline hydrochloride."TALANTA.2025 Mar;:127977 59. [IF=1.4] Yan Y. T. et al."Self-Assembling Ceramide 2-Cyclodextrin Inclusion Nanoparticles for Corneal Repair."COLLOID JOURNAL.2024 Aug;86(4):644-654 58. [IF=7.7] Huan Guo et al."Development of pectin/chitosan-based electrospun biomimetic nanofiber membranes loaded with dihydromyricetin inclusion complexes for wound healing application."INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES.2024 Aug;:134526 57. [IF=6.1] Lin Zhu et al."Preparation and characterization of tea tree essential oil microcapsule-coated packaging paper with bacteriostatic effect."Food Chemistry-X".2024 Oct;23:101510 56. [IF=5.9] Jialing Huang et al."Development of a Syzygium aromaticum, L. essential oil/hydroxypropyl-β-cyclodextrin inclusion complex: Preparation, characterization, and evaluation."INDUSTRIAL CROPS AND PRODUCTS".2024 Aug;214:118500 55. [IF=10.2] Shen Huan et al."Asiatic acid cyclodextrin inclusion micro-cocrystal for insoluble drug delivery and acute lung injury therapy enhancement."JOURNAL OF NANOBIOTECHNOLOGY".2024 Dec;22(1):1-13 54. [IF=7.3] Jianbei Xi et al."Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis."JOURNAL OF MEDICINAL CHEMISTRY.2023;66(23):15926–15943 53. [IF=7.3] Yue Li et al."Discovery of a First-in-Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy."JOURNAL OF MEDICINAL CHEMISTRY.10.1021/acs.jmedchem.3c00391 52. [IF=0] Zhao Yun-Qiu et al."Unravelling and engineering an operon involved in the side-chain degradation of sterols in Mycolicibacterium neoaurum for the production of steroid synthons."Biotechnology for Biofuels and Bioproducts.2023 Dec;16(1):1-17 51. [IF=9.5] Yuqin Zhang et al."Cyclodextrin-Coordinated Liposome-in-Gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment."ACS Applied Materials & Interfaces.2023;XXXX(XXX):XXX-XXX 50. [IF=9.9] Ma Jiajia et al."Adaptable “bubble particles” prepared by green aqueous phase reshaping for completely removing odor."Nano Research.2023 Aug;:1-9 49. [IF=2.586] Junyu Chen et al."HGF-modified human umbilical cord mesenchymal stem cells rescue impaired ovarian reserve function in chemotherapy-induced POI rats by improving angiogenesis while decreasing apoptosis and fibrosis in the ovary."TISSUE & CELL.2023 May;:10 48. [IF=2.213] Lin Li et al."Study on Quality Control of Tenofovir Disoproxil Fumarate Enantiomers by High-Performance Liquid Chromatography–Mass Spectrometry."CHROMATOGRAPHIA.2023 Feb;:1-10 47. [IF=5.561] Qing Li et al."Microencapsulation with Different Starch-Based Polymers for Improving Oxidative Stability of Cold-Pressed Hickory (Carya cathayensis Sarg.) Oil."Foods.2023 Jan;12(5):953 46. [IF=3.841] Congcong Wang et al."Fabrication of Hesperetin/hydroxypropyl-β-cyclodextrin Complex Nanoparticles for Enhancement of Bioactivity Using Supercritical Antisolvent Technology."JOURNAL OF MOLECULAR STRUCTURE.2023 Jan;:134947 45. [IF=5.561] Hongbo Li et al."Encapsulation of Benzyl Isothiocyanate with β-Cyclodextrin Using Ultrasonication: Preparation, Characterization, and Antibacterial Assay."Foods.2022 Jan;11(22):3724 44. [IF=9.147] Maoyun Li et al."Development and characterization of active bilayer film incorporated with dihydromyricetin encapsulated in hydroxypropyl-β-cyclodextrin for food packaging application."FOOD HYDROCOLLOIDS. 2022 Oct;131:107834 43. [IF=6.953] Wen Zhu et al."Artemisinin hydroxypropyl-β-cyclodextrin inclusion complex loaded with porous starch for enhanced bioavailability."INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 2022 Jun;211:207 42. [IF=4.411] Jifen Zhang et al."A Novel Solid Nanocrystals Self-Stabilized Pickering Emulsion Prepared by Spray-Drying with Hydroxypropyl-β-cyclodextrin as Carriers."Molecules. 2021 Jan;26(6):1809 41. [IF=4.539] Bo Zhang et al."Use of hydroxypropyl β-cyclodextrin as a dual functional component in xanthan hydrogel for sustained drug release and antibacterial activity."Colloid Surface A. 2020 Feb;587:124368 40. [IF=4.939] Wenqiang Su et al."Inhalation of Tetrandrine-hydroxypropyl-β-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment."Mol Pharmaceut. 2020;17(5):1596–1607 39. [IF=6.165] Shaoping Ma et al."Deep-eutectic solvents simultaneously used as the phase-forming components and chiral selectors for enantioselective liquid-liquid extraction of tryptophan enantiomers."J Mol Liq. 2020 Dec;319:114106 38. [IF=1.633] Wan Hui-da et al."Enzymatic production of steviol using a commercial β-glucosidase and preparation of its inclusion complex with γ-CD."J Incl Phenom Macro. 2019 Apr;93(3):193-201 37. [IF=5.875] Chao Hong et al."Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: An in vitro and in vivo evaluation."Int J Pharmaceut. 2014 Dec;477:251 36. [IF=6.044] Yashu Yao et al."Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: Preparation, characterization, and evaluation."Carbohyd Polym. 2014 Sep;110:329 35. [IF=7.312] Runping Wang et al."Biphasic recognition chiral extraction of threonine enantiomers in a two-phase system formed by hydrophobic and hydrophilic deep-eutectic solvents."Sep Purif Technol. 2019 May;215:102 34. [IF=9.381] Qiuna Zhou et al."Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins."Carbohyd Polym. 2013 Jun;95:733 33. Yanping Wu, Yue Xiao, Yuxi Yue, Kai Zhong, Yinglan Zhao, Hong Gao, A deep insight into mechanism for inclusion of 2R,3R-dihydromyricetin with cyclodextrins and the effect of complexation on antioxidant and lipid-lowering activities, Food Hydrocolloids, Vol 32. Ma, Shaoping, et al. "Deep-eutectic solvents simultaneously used as the phase-forming components and chiral selectors for enantioselective liquid-liquid extraction of tryptophan enantiomers." Journal of Molecular Liquids 319 (2020): 114106.https://doi.org/ 31. Wang, Runping, et al. "Biphasic recognition chiral extraction of threonine enantiomers in a two-phase system formed by hydrophobic and hydrophilic deep-eutectic solvents." Separation and Purification Technology 215 (2019): 102-107.https://doi.org/10.1016/j 30. Yao, Yashu, et al. "Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: Preparation, characterization, and evaluation." Carbohydrate polymers 110 (2014): 329-337.https://doi.org/10.1016/j.carbpol.2014.04.006 29. Hong, Chao, et al. "Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation." International journal of pharmaceutics 477.1-2 (2014): 251-260.https://doi.org/10.1016/j.ijpharm 28. 楊擋,封亮,劉俊,趙菁,李超,朱法根,邵建國,賈曉斌,孫娥.基于物料性質(zhì)表征技術(shù)的蒲地藍消炎口服液兒童用藥順應(yīng)性改善研究[J].世界中醫(yī)藥,2020,15(15):2221-2227. 27. 張利竣,吳盈盈,吳瑾瑾,石森林.燈盞花素溫敏型鼻用原位凝膠的體外釋放和生物黏附性考察[J].中國現(xiàn)代應(yīng)用藥學(xué),2020,37(23):2863-2867. 26. 楊擋,封亮,劉俊,趙菁,李超,朱法根,邵建國,賈曉斌,孫娥.基于物料性質(zhì)表征技術(shù)的蒲地藍消炎口服液兒童用藥順應(yīng)性改善研究[J].世界中醫(yī)藥,2020,15(15):2221-2227. 25. 韓東旭,李天樂,苗瑞丹,王瑤,劉麗艷,于湛.七-(2,6-二甲基)-β-環(huán)糊精對木犀草素的增溶研究[J].中國現(xiàn)代應(yīng)用藥學(xué),2020,37(22):2747-2751. 24. 劉忠博. 基于環(huán)糊精的食品級Pickering乳液構(gòu)建[D].河南科技學(xué)院,2021. 23. 張波,蘇衍華,龐麗艷,陳章良,李兆樓,王鳳琴.卡拉膠/瓊脂/羥丙基-β-環(huán)糊精復(fù)合凝膠的合成及其載藥性能研究[J].濟寧醫(yī)學(xué)院學(xué)報,2020,43(04):242-247. 22. 庫爾班江·巴拉提. 槲皮素環(huán)糊精包合物的制備工藝及溶解性研究[J]. 食品安全質(zhì)量檢測學(xué)報, 2016. 21. 石光 邱野 高雯 等. 參紅通絡(luò)顆粒制備工藝中揮發(fā)油穩(wěn)定化方法的研究[J]. 時珍國醫(yī)國藥 2015(05):1133-1135. 20. 郤慶, 吳婉靜, 李國文. 楊梅素羥丙基-β-環(huán)糊精包合物的制備[J]. 藥學(xué)服務(wù)與研究, 2016, 16(003):211-215. 19. 趙源征, 張敏, 劉恒方,等. 黃體酮對大鼠局灶性腦缺血后血腦屏障的保護[J]. 醫(yī)藥論壇雜志, 2014, 035(009):5-7. 18. 鐘賽意, 劉壽春, 陳建平,等. 高良姜油-羥丙基-β-環(huán)糊精包合物的抗氧化活性及抑制亞硝胺合成作用[J]. 食品科學(xué), 2018, 39(19):127-134. 17. 朱士龍, 陳迪釗, 李勇,等. 青藤堿與羥丙基-β-環(huán)糊精的包合作用[J]. 精細(xì)化工, 2012(02):60-64+109. 16. 陸兆光, 萬琴, 孟瑾,等. 青蒿揮發(fā)油羥丙基-β-環(huán)糊精包合物的制備及其抗病毒活性分析簡[J]. 中國實驗方劑學(xué)雜志, 2018(18):11-15. 15. 劉平安, 何群, 李順祥,等. 鐵皮石斛滴眼液的制備工藝研究. 14. 韋小翠, 楊書婷, 張焱,等. 都梁方中揮發(fā)油β-環(huán)糊精包合物的制備[J]. 中成藥, 2019, 41(04):7-12. 13. 樊保民, 郝華, 楊彪,等. 超分子緩蝕劑在冷凝水管線鋼表面的組裝機理[J]. 表面技術(shù), 2018, v.47(10):33-40. 12. 關(guān)秀鋒, 王銳, 楊婧. 蛇床子環(huán)糊精包合物接枝溫敏凝膠的制備與體外釋放[J]. 化學(xué)工程師, 2019, 033(012):63-67. 11. 沈新宇,徐蓉蓉,王星辰,黃罡,胡榮.薏苡素-2-羥丙基-β-環(huán)糊精包合物凍干粉的制備和表征[J].中國新藥雜志,2019,28(16):2040-2048. 10. 李進霞, 于肯明, 張慧芝,等. 芹菜素-環(huán)糊精包合物在溶液中的制備,表征及抗氧化性[J]. 山西大同大學(xué)學(xué)報(自然科學(xué)版), 2015, 000(006):40-43. 9. 趙厚菲, 呼芷晴, 徐永霞,等. 肉桂醛-羥丙基-β-環(huán)糊精包合物的噴霧干燥法制備及表征[J]. 包裝與食品機械, 2020, 038(001):25-29. 8. 姜慧明,楊紅.羥丙基β-環(huán)糊精對多菌靈的熒光增敏效應(yīng)[J].沈陽農(nóng)業(yè)大學(xué)學(xué)報,2013,44(06):820-822. 7. 段友構(gòu), 朱士龍, 張浚生,等. 環(huán)糊精對青蒿素的包合工藝研究[J]. 食品科學(xué), 2013, 34(008):89-93. 6. 徐磊, 蔣劍平, 金銘,等. 溫莪術(shù)油羥丙基-β-環(huán)糊精包合物的制備與表征[J]. 中華中醫(yī)藥雜志, 2015(4):1043-1046. 5. 王銳, 李建月, 楊婧. 川芎提取物接枝型鼻用溫敏凝膠制備及藥效學(xué)研究[J]. 上海中醫(yī)藥雜志, 2019, v.53;No.593(06):92-97. 4. 張曉沖, 廖啟元, 翟光喜. 姜黃素包合物胃內(nèi)漂浮微球的研制[J]. 現(xiàn)代中藥研究與實踐, 2014, 028(001):56-59. 3. 王曉娟, 王魁麟, 陸兆光,等. 姜黃揮發(fā)油羥丙基-β-環(huán)糊精包合物的制備、穩(wěn)定性及其抗真菌活性[J]. 中國新藥與臨床雜志, 2019, 038(007):433-439. 2. 周慧 鄭一敏 胥秀英. 雙氫青蒿素-羥丙基-β-環(huán)糊精包合物的制備工藝研究[J]. 中國當(dāng)代醫(yī)藥 2016 23(008):9-11. 1. 姜慧明 楊紅. β-環(huán)糊精對多菌靈的熒光增敏效應(yīng)研究[J]. 大連民族大學(xué)學(xué)報 2014 16(1):5-9.